Anxo Pharmaceutical Co., Ltd. (TPEX:6677)
Taiwan · Delayed Price · Currency is TWD 19.80
-0.05 (-0.25%)
Jan 22, 2026, 2:03 PM CST
Anxo Pharmaceutical Market Cap
Anxo Pharmaceutical has a market cap or net worth of 1.11 billion as of January 22, 2026. Its market cap has decreased by -18.21% in one year.
Market Cap
1.11B
Enterprise Value
1.63B
Revenue
883.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.80
Market Cap Chart
Since June 27, 2018, Anxo Pharmaceutical's market cap has decreased from 2.16B to 1.11B, a decrease of -48.73%. That is a compound annual growth rate of -8.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 1.11B | 5.60% |
| Dec 31, 2025 | 1.05B | -21.58% |
| Dec 31, 2024 | 1.34B | -50.67% |
| Dec 29, 2023 | 2.71B | 89.95% |
| Dec 30, 2022 | 1.43B | 20.33% |
| Dec 30, 2021 | 1.18B | -13.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 254.20B |
| PharmaEssentia | 213.40B |
| Lotus Pharmaceutical | 84.02B |
| Heron Neutron Medical | 69.56B |
| Bora Pharmaceuticals Co., LTD. | 65.48B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 31.25B |
| Center Laboratories | 31.09B |